The past several decades were a time of fundamental discoveries for immunologists who had to learn a new language-a complex vocabulary of molecules, cell subsets, and pathways. This collective work has reached a maturity that can facilitate the integration of complex systems for the exploration of human health. The focus of immunology has shifted from a reductionist point of view to the exploration of microenvironments within tissues, infectious sites, or tumors. Immunity is now assessed in the context of internal and external circumstances including environment, life exposure, age, nutrition, and our rapidly evolving partners, the microbiota. Paradoxically, this has allowed the field of immunology to return to a concept originally described in the 19 th century by Claude Bernard as the ''milieu inté rieur'' and referred to today as homeostasis. The extraordinary plasticity and motility of immune cells allows bridging virtually all physiological systems, making the immune system a central regulator of host homeostasis. This holistic understanding is transforming immunology, which is repositioning itself as a highly organic discipline that absorbs other branches of biology and quickly embraces technological advances. With it comes the formidable task of developing, once again, a new language. This will require novel forms of training for the next generation of immunologists, combined with restructuration of laboratories and research organizations in a way that further embraces and integrates the enormous complexity and dynamic interplay of biological systems.
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As an immunologist, I can't help noticing how many colleagues outside the field seem to have been traumatized by the first immunology lectures they ever heard. They seem to regard it much the way Ambrose Bierce defined philosophy as ''A route of many roads, leading from nowhere to nothing.'' The good news is that from the efforts of many hardworking people, we now know a tremendous amount of facts and principles about the immune system. In particular, the inbred mouse model, which immunologists were early adopters of, has been intensely studied with the many tools available. Mouse studies set the stage for the next level of both difficulty and opportunity for our field, which is tackling the human ''model.'' This represents a major opportunity because we have already seen evidence that the immune system of humans has much to teach us about the immune system of outbred long-lived primates, exposed to a myriad of diseases and treatments. It should bring us much closer to a better understanding and treatment of patients with any of the huge variety of diseases that involve the immune system: autoimmunity, ineffective vaccines, cancer, heart disease-something the mouse model has generally been not been very good at. Difficulties? There are many. New technologies and strategies are needed, and also closer connections between the clinical and scientific worlds, since there is an immense amount of medical know and expertise that must be drawn upon. There will be confusion again, as in the early days. After all, we are only interested in things we don't understand! 
